carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Olux E Foam® Launches
Released: 02/04/2013
By: Mike Partridge, RPh

On February 1, 2013, Perrigo received final FDA approval for and commenced shipping the generic equivalent for Stiefel Laboratories’ branded product, Olux E Foam® (clobetasol propionate). Olux E Foam® had estimated total U.S. annual sales of approximately $40 million.
Olux E Foam® is a corticosteroid indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer